Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI033852-03
Application #
2068917
Study Section
AIDS and Related Research Study Section 3 (ARRC)
Project Start
1994-08-01
Project End
1999-04-30
Budget Start
1996-05-01
Budget End
1997-04-30
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Stanford University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305

  Publications

Vana, Marcy L; Formankova, Danuse; Cha, Steven et al. (2008) Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation. Clin Infect Dis 47:535-9
Noda, Satoshi; Aguirre, Shirley A; Bitmansour, Andrew et al. (2006) Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood 107:30-8
Abate, Davide A; Watanabe, Shinya; Mocarski, Edward S (2004) Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol 78:10995-1006
Hertel, Laura; Mocarski, Edward S (2004) Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of Pseudomitosis independent of US28 function. J Virol 78:11988-2011
Slobedman, Barry; Stern, J Lewis; Cunningham, Anthony L et al. (2004) Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J Virol 78:4054-62
Hertel, Laura; Lacaille, Vashti G; Strobl, Herbert et al. (2003) Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol 77:7563-74
Slobedman, Barry; Mocarski, Edward S; Arvin, Ann M et al. (2002) Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood 100:2867-73
Saederup, N; Aguirre, S A; Sparer, T E et al. (2001) Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J Virol 75:9966-76
White, K L; Slobedman, B; Mocarski, E S (2000) Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection. J Virol 74:9333-7
Slobedman, B; Mocarski, E S (1999) Quantitative analysis of latent human cytomegalovirus. J Virol 73:4806-12

Showing the most recent 10 out of 17 publications